Abstract: A method of classifying an infectious disease in a subject are disclosed. The method comprises: (a) measuring the amount of at least one protein set forth in Table 4 and at least one protein set forth in Table 6 in a sample derived from the subject; and (b) ruling in or ruling out a viral disease based on the amount of the at least one protein set forth in Table 4 and determining the severity of the viral disease based on the amount of the at least one protein set forth in Table 6.

Abstract: The present invention discloses oral compositions for nourishment of a mammalian subject which comprises steviol glycoside, citric acid monohydrate, monosodium glutamate and/or glycine. These compositions, being highly palatable, increase consumption of said composition, further configured to decrease mortality rate, increase weight gain, reduced use of either antibiotics or milk replacers and improve small intestine anatomy of said mammalian.

Abstract: The present invention discloses oral isotonic compositions to provide hydration to mammals in need, comprising a prebiotic oligosaccharide or fructo-oligosaccharide and at least three members of the group consisting of steviol glycoside, citric acid monohydrate, glutamic acid, monosodium glutamate and glycine.

Abstract: A method includes receiving a multi-channel audio signal (101) including multiple input audio channels (102, 104, 106, 108) that are configured to play audio from multiple respective locations relative to a listener. One or more spectral components that undergo a panning effect (1001, 1002, 1003) are identified in the multi-channel audio signal among at least some of the input audio channels. One or more virtual channels (1100, 1200, 1300) are generated, which together with the input audio channels form an extended set (111) of audio channels that retain the identified panning effect. A reduced set (222) of output audio signals, fewer in number than the input audio signals, is generated from the extended set, including recreating the panning effect in the output audio signals. The reduced set of output audio signals is outputted to a user.

Abstract: The present invention discloses methods and compositions for nourishing newly-borne mammals; specifically, reducing antibiotic usage, increasing weight and increasing immunoglobulin concentrations in said newly borne mammals, following oral treatment of pregnant mammals of said newly-borne mammals. The compositions of the current invention have chicken, beef, fish or apple flavouring.

Abstract: The present invention discloses palatable oral formulations for hydrating, supporting gut activity, micronutrient supplementation and providing oral carriers for vaccines, antibiotics and food supplements, of inter alia, companion or pet animals.

Abstract: A method includes receiving a multi-channel audio signal (101) including multiple input audio channels (102, 104, 106, 108) that are configured to play audio from multiple respective locations relative to a listener. One or more spectral components that undergo a panning effect (1001, 1002, 1003) are identified in the multi-channel audio signal among at least some of the input audio channels. One or more virtual channels (1100, 1200, 1300) are generated, which together with the input audio channels form an extended set (111) of audio channels that retain the identified panning effect. A reduced set (222) of output audio signals, fewer in number than the input audio signals, is generated from the extended set, including recreating the panning effect in the output audio signals. The reduced set of output audio signals is outputted to a user.

Abstract: The present invention discloses oral isotonic compositions to provide hydration to mammals in need, characterized by no residual chlorine taste, comprising at least three members of a group consisting of steviol glycoside, citric acid monohydrate, glutamic acid, monosodium glutamate and glycine.

Abstract: The present invention discloses compositions which comprises steviol glycoside, citric acid monohydrate, monosodium glutamate and/or glycine. Furthermore, the invention provides diets, nutraceuticals and nutrition oral rehydration therapy, means and methods useful in treating and inducing of remission of inflammation in IBD patients.

Abstract: An oral rehydration composition comprising the following: 1-glutamic acid in a range of about 0.01% to about 0.40% w/w and monosodium glutamate in a range of about 0.05% to about 0.80% w/w; about 1.50% w/w glucose monohydrate; about 0.20% w/w sodium chloride; about 0.15% w/w potassium chloride; about 0.35% w/w glycine; about 0.30% w/w trisodiumcitrate; about 0.15% w/w sodium dihydrogen phosphate; about 0.10% w/w xanthan gum; 85% Steviol Glycoside extract in a range of about 0.01% to about 0.03% w/w; about 0.20% w/w citric acid monohydrate; hydrolyzed whey in a range of about 0.15% to about 1.00% w/w; about 1.00% w/w hydrolyzed wheat; comprises cereals as a protein source; comprises enzyme co-factors; comprises a monosaccharide. The oral rehydration composition can be used on humans or animals that suffer from diarrhea.

Abstract: An oral rehydration composition comprising the following: 1-glutamic acid in a range of about 0.01% to about 0.40% w/w and monosodium glutamate in a range of about 0.05% to about 0.80% w/w; about 1.50% w/w glucose monohydrate; about 0.20% w/w sodium chloride; about 0.15% w/w potassium chloride; about 0.35% w/w glycine; about 0.30% w/w trisodiumcitrate; about 0.15% w/w sodium dihydrogen phosphate; about 0.10% w/w xanthan gum; 85% Steviol Glycoside extract in a range of about 0.01% to about 0.03% w/w; about 0.20% w/w citric acid monohydrate; hydrolyzed whey in a range of about 0.15% to about 1.00% w/w; about 1.00% w/w hydrolyzed wheat; comprises cereals as a protein source; comprises enzyme co-factors; comprises a monosaccharide. The oral rehydration composition can be used on humans or animals that suffer from diarrhea.

Abstract: The present invention discloses oral compositions for nourishment a mammalian subject which comprises steviol glycoside, citric acid monohydrate, monosodium glutamate and/or glycine. These compositions, being highly palatable, increase consumption of said composition, further configured to decrease mortality rate, increase weight gain, reduced use of either antibiotics or milk replacers and improve small intestine anatomy of said mammalian.

Abstract: The present invention discloses compositions which comprises steviol glycoside, citric acid monohydrate, monosodium glutamate and/or glycine. Furthermore, the invention provides diets, nutraceuticals and nutrition oral rehydration therapy, means and methods useful in treating and inducing of remission of inflammation in IBD patients.

Abstract: A method of collecting a urine sample including appropriately locating hydrophobic sand with respect to the urine sample. Use of the hydrophobic sand including providing a barrier in the form of at least one layer of the sand; and collecting a urine sample by appropriately locating the sand with respect to the urine.

Abstract: An oral rehydration composition comprising the following: 1-glutamic acid in a range of about 0.01% to about 0.40% w/w and monosodium glutamate in a range of about 0.05% to about 0.80% w/w; about 1.50% w/w glucose monohydrate; about 0.20% w/w sodium chloride; about 0.15% w/w potassium chloride; about 0.35% w/w glycine; about 0.30% w/w trisodiumcitrate; about 0.15% w/w sodium dihydrogen phosphate; about 0.10% w/w xanthan gum; 85% Steviol Glycoside extract in a range of about 0.01% to about 0.03% w/w; about 0.20% w/w citric acid monohydrate; hydrolyzed whey in a range of about 0.15% to about 1.00% w/w; about 1.00% w/w hydrolyzed wheat; comprises cereals as a protein source; comprises enzyme co-factors; comprises a monosaccharide. The oral rehydration composition can be used on humans or animals that suffer from diarrhea.

Abstract: A system and method fir guiding a supply chain management system user belonging to an organization, comprising: retrieving a list of said user's available actions; retrieving a list of said organization's business partners relevant to said user; retrieving a list of all currently active business processes involving said relevant business partners; deriving required actions for each retrieved process; cross referencing said derived actions with said user's permissions and filtering them accordingly; prioritizing said filtered actions; grouping similar actions; creating a task for each group of similar actions; and linking said tasks to relevant documents.

Abstract: A supply chain management system comprising: a system server comprising a central processor and a database; a plurality of user computers communicating with the system server over a network; the system server running a software process defining: an interface layer configured to communicate messages and business transactions bi-directionally between the user computers and the system server; and a services layer configured to apply business logic to the messages and business transaction and process them according to a predefined workflow of the supply chain management system; the plurality of user computers running client applications configured to communicate with the interface layer, the client applications comprising a virtual printer driver and virtual cloud printer application configured to virtually print documents into the system using the virtual print driver; the service layer comprising a cloud printer service configured to communicate bi-directionally with the virtual cloud printer application and wi

Abstract: A method of automatically mapping a transaction schema to a supply chain management system, comprising: receiving a XML document schema and type; retrieving a corresponding dictionary comprising unified format keys; parsing the document file; retrieving a XML tag; understanding the tag; and mapping the tag to one of said dictionary's keys.